Literature DB >> 25110623

Acute HIV infection presenting as fulminant meningoencephalitis with massive CSF viral replication.

Rosa M Andrade1, Francesca J Torriani1, Ronald J Ellis1.   

Abstract

A 22-year-old man presented to the emergency department with 10 days of malaise, generalized rash, sore throat, oral ulcers, headache, nausea, and vomiting. On examination he had fever (101.5°F), hepatosplenomegaly, generalized maculopapular rash, and lymphadenopathy. He rapidly became obtunded, requiring intubation. Initial laboratory studies showed mild transaminitis, increased lactate dehydrogenase, and 4,600 leukocytes per μL with 61% bands and 18% lymphocytes. Bacterial and fungal blood cultures were negative as well as a rapid HIV test, additional serologies (including rapid plasma reagin and Treponema pallidum particle agglutination), quantitative PCRs (for viruses other than HIV), and urine and blood toxicology. CSF, on hospital day 4, showed a lymphocytic pleocytosis (total leukocytes: 100), high protein, borderline hypoglycorrhachia, and negative Gram stain and culture. Brain MRI revealed no meningeal enhancement or masses. EEG revealed no epileptiform activity. Flow cytometry on bone marrow biopsy and CSF found no evidence of malignancy; neither did an excisional lymph node biopsy (figure 1). An immunofluorescent assay test for HIV returned inconclusive and a Western blot detected HIV gp120/gp160 bands. Quantitative HIV RNA PCR was 1.4 × 106 copies/mL in plasma and in CSF exceeded the upper limit of quantitation (107 copies/mL) (figure 2).

Entities:  

Year:  2014        PMID: 25110623      PMCID: PMC4121464          DOI: 10.1212/CPJ.0000000000000037

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  6 in total

1.  Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings.

Authors:  Amy C Weintrob; Julieta Giner; Prema Menezes; Ericka Patrick; Daniel Kelly Benjamin; Jeffrey Lennox; Christopher D Pilcher; Joseph J Eron; Charles B Hicks
Journal:  Arch Intern Med       Date:  2003-09-22

2.  Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders.

Authors:  Scott L Letendre; J Allen McCutchan; Meredith E Childers; Steven P Woods; Deborah Lazzaretto; Robert K Heaton; Igor Grant; Ronald J Ellis
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

3.  Acute encephalopathy and multi-organ involvement with rhabdomyolysis during primary HIV infection.

Authors:  Miltiadis Douvoyiannis; Nathan Litman
Journal:  Int J Infect Dis       Date:  2009-03-25       Impact factor: 3.623

4.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Authors:  L E Davis; B L Hjelle; V E Miller; D L Palmer; A L Llewellyn; T L Merlin; S A Young; R G Mills; W Wachsman; C A Wiley
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

5.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors:  Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal:  Arch Neurol       Date:  2008-01

6.  Neurocognitive functioning in acute or early HIV infection.

Authors:  David J Moore; Scott L Letendre; Sheldon Morris; Anya Umlauf; Reena Deutsch; Davey M Smith; Susan Little; Alexandra Rooney; Donald R Franklin; Ben Gouaux; Shannon Leblanc; Debra Rosario; Christine Fennema-Notestine; Robert K Heaton; Ronald J Ellis; J Hampton Atkinson; Igor Grant
Journal:  J Neurovirol       Date:  2010-12-15       Impact factor: 2.643

  6 in total
  1 in total

Review 1.  Update and New Directions in Therapeutics for Neurological Complications of HIV Infections.

Authors:  Ronald Ellis; Scott L Letendre
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.